Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Valuing the Endangered Species Antirrhinum lopesianum: Neuroprotective Activities and Strategies for in vitro Plant Propagation.
Smoking as a risk factor for development of Secondary Progressive Multiple Sclerosis: A study in IRAN, Guilan.
Neuro-Behçet's disease, its mimickers and anti-TNF therapy: a case-based review.
A New Approach for Deep Gray Matter Analysis Using Partial-Volume Estimation.
T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression.
Microglia in central nervous system repair after injury.
The GSTP1 gene variant rs1695 is not associated with an increased risk of multiple sclerosis.
Autophagy and neurodegeneration.
A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway.
Behavioural changes observed in demyelination model shares similarities with white matter abnormalities in humans.
PANGAEA: Post-authorization Noninterventional German Safety Study of GilEnyA in relapsing-remitting multiple sclerosis (RRMS) patients: A 24-month interim analysis of a German five-year fingolimod registry study.
Novel diagnostic tools and solutions for multiple sclerosis treatment: a patent review (2009 - 2014).
Baseline MxA mRNA Expression Predicts Interferon Beta Response in Multiple Sclerosis Patients.
Fingolimod efficacy in multiple sclerosis associated with Sjogren syndrome.
Multiple sclerosis and pregnancy: a single-centre prospective comparative study.
Voxel-Wise Displacement as Independent Features in Classification of Multiple Sclerosis.
Comparison of 3D Cube FLAIR with 2D FLAIR for Multiple Sclerosis Imaging at 3 Tesla.
Serum levels of brain-derived neurotrophic factor (BNDF) in multiple sclerosis patients with Trichuris suis ova therapy.
Strategies used by individuals with multiple sclerosis and with mild disability to maintain dynamic stability during a steering task.
Transcription factor induction of human oligodendrocyte progenitor fate and differentiation.
Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosis.
Acute hemorrhagic leukoencephalitis (Weston-Hurst syndrome) in a patient with relapse-remitting multiple sclerosis.
Computational modeling of cytokine signaling in microglia.
Oligodendrocyte Precursor Cells in Spinal Cord Injury: A Review and Update.
Female sexual dysfunction in multiple sclerosis: Results of a survey among Dutch urologists and patients.
Pages
« first
‹ previous
…
445
446
447
448
449
450
451
452
453
…
next ›
last »